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Introduction
Magnetic resonance imaging (MRI) is a useful diagnostic tool for evaluation of 
congenital or acquired brain lesions, dysmyelination or demyelination, gliosis, 
primary and metastatic brain tumors, cerebral edema, and acute stroke. But, in all 
of less than 8-year-old children, pharmacological agents and procedural sedation 
should be used to induce motionless conditions for imaging studies (1), for which 
different sedation regimens may be used in radiology departments (2,3). 
Schulte-Uentrop and Goepfert (4) in their research concluded that dexmedetomidine 
may be convenient for MRI sedation of children without cardiac risk. But, the 
drug is expensive and hardly available in many developing countries such as Iran. 
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Abstract
Objective 
Magnetic resonance imaging (MRI) is a useful diagnostic tool for the evaluation 
of congenital or acquired brain lesions. But, in all of less than 8-year-old children, 
pharmacological agents and procedural sedation should be used to induce 
motionless conditions for imaging studies. The purpose of this study was to 
compare the efficacy and safety of combination of chloral hydrate-hydroxyzine 
(CH+H) and chloral hydrate-midazolam (CH+M) in pediatric MRI sedation. 
Materials & Methods
In a parallel single-blinded randomized clinical trial, sixty 1-7-year-old children 
who underwent brain MRI, were randomly assigned to receive chloral hydrate 
in a minimum dosage of 40 mg/kg in combination with either 2 mg/kg of 
hydroxyzine or 0.5 mg/kg of midazolam. The primary outcomes were efficacy 
of adequate sedation (Ramsay sedation score of five) and completion of MRI 
examination. The secondary outcome was clinical side-effects.
Results
Twenty-eight girls (46.7%) and 32 boys (53.3%) with the mean age of 2.72±1.58 
years were studied. Adequate sedation and completion of MRI were achieved in 
76.7% of CH+H group. Mild and transient clinical side-effects, such as vomiting 
of one child in each group and agitation in 2 (6.6 %) children of CH+M group, 
were also seen. The adverse events were more frequent in CH+M group.
Conclusion
Combinations of chloral hydrate-hydroxyzine and chloral hydrate-midazolam 
were effective in pediatric MRI sedation; however, chloral hydrate-hydroxyzine 
was safer. 
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Chloral hydrate (CH) is a non-opiate, non-
benzodiazepine sedative-hypnotic drug, which has 
been used for pediatric sedation in a dosage of 40-100 
mg/kg for many years (3,5). But, it was not effective 
in some children, even at maximum dosage, and there 
are concerns about its long acting duration, obstruction 
of airway, respiratory depression with intra- and 
post-procedural oxygen desaturation, sedative effects 
consistency, and its potential for carcinogenicity, 
especially at high doses (5-7).
Chloral hydrate at a dose of 40 mg/kg is safer and 
its combination with antihistamines might decrease 
chloral hydrate dosage (7,8).
Combination of chloral hydrate and hydroxyzine has 
been used for sedation of children in dental procedures, 
and it can decrease the required dosage of chloral 
hydrate and also cause improvement in safer sleeping 
of patient and decrease the risk of chloral hydrate 
related nausea and vomiting (9).
Midazolam is a water-soluble benzodiazepine, which 
can be used in different routes (oral, intravenous, 
intramuscular, rectal, sublingual, aerosolized buccal, 
and intranasal) for sedation induction in children 
(10,11). 
Oral midazolam is a non-parenteral route, which does 
not cause pain of injection and is used at dosages of 
0.5-1 mg/kg in pediatric sedation induction (12). 
The purpose of this study was to compare the efficacy 
and safety of chloral hydrate at minimum dosage 
in combination with hydroxyzine or midazolam in 
pediatric MRI sedation induction.
Materials & Methods
We followed a randomized single-blind study on 
children who underwent sedation for elective MRI at the 
Radiology Department of a tertiary-care hospital (Shahid 
Sadoughi Hospital) in Yazd, Iran from November 2012 
to March 2013.
An Informed consent was taken from patients’ parents 
before the administration of the drugs, and the study was 
approved by the Ethics Committee of Shahid Sadoughi 
University of Medical Sciences, Yazd, Iran.
The sample size was calculated to be 30 children in each 
group to detect a 20% difference in efficacy between the 
two groups with type one error (alpha) of 0.05 and 80% 
power. Eligible participants included children aged 1-7 
years, who were in American Society of Anesthesiology 
(ASA) class 1 (a normally healthy patient) or 2 (a patient 
with mild systemic disease: mild asthma, controlled 
diabetes mellitus, etc.) (13).
Exclusion criteria consisted of presence of gastritis or 
any other serious systemic diseases, severe systemic 
reaction, head injury, and receiving a sedative hypnotic 
agent within the past 48 hours.
The trial used computer generated equal simple 
randomization by random numbers, and allocation ratio 
was 1:1 for the two groups. 
Randomization and blinding were performed by an 
investigator with no clinical involvement in the trial. 
Data collectors, outcome assessors, and data analysts 
were all kept blinded to the allocation. But, patients and 
an MRI nurse allocated to the intervention group, were 
aware of the allocated arm. A pharmacist prepared the 
drugs, which were given in a suspension of 1 cc/kg. 
The drug combination was delivered by MRI nurses 
who had certificates in pediatric advanced life support 
and basic life support, when the participants entered the 
preparation room. Primary and secondary outcomes were 
assessed by a pediatric resident who was not informed of 
the group assignment of drug combination. 
The children were randomly assigned to two groups to 
receive either 40 mg/kg of chloral hydrate and 2 mg/kg 
of hydroxyzine (Group I) or 40 mg/kg of chloral hydrate 
and 0.5 mg/kg of midazolam (Group II). 
Ramsay sedation scale was used for assessment of 
the sedation level (14), and it was measured every 
10 minutes. The Ramsay sedation scale of five was 
considered as adequately deep sedation. 
The primary outcomes were efficacy in adequate deep 
sedation and completion of MRI examination.
The secondary outcomes included clinical side-effects, 
serious adverse events (hypotension, hypoxia and 
cyanosis, severe vomiting, intractable irritability and 
agitation, apnea, laryngospasm, and bradycardia), time 
from administration of the drug combination to adequate 
sedation, caregiver’s satisfaction on a likert scale of 1-5 
(1= completely unsatisfied; 2= partially unsatisfied; 
3= partially satisfied; 4= satisfied; and 5=completely 
satisfied), and total stay time in MRI center.
Respiratory depression requiring assisted ventilation, 
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showed that the efficacy of both drugs combination in 
the sedation induction was not statistically different 
(p=0.76).
Also, the quality of MRI was not significantly different 
between the two groups (Table 1).
Table 2 shows comparison of the mean of acquired 
Ramsay sedation score, time between drugs taking and 
reaching the Ramsey score of five, caregiver’s satisfaction 
scale, and total stay time in radiology department which 
indicates that in chloral hydrate-hydroxyzine group, 
parents waited less in the radiology department.
Comparison of completion of MRI examination in both 
groups based on developmental status and age group 
is shown in Table 3, which indicates that the efficacy 
of both drugs combination in sedation induction was 
not statistically different in children with and without 
developmental delay, in infants (less than two years old), 
and also in children.
Probability of being adequately sedated vs. time after 
taking the drugs is shown in Kaplan–Meier plots in 
figure 1, which indicates that Ramsay sedation score of 
five was obtained in all children who achieved adequate 
sedation 40 minutes after taking the drugs combination. 
No serious adverse events were seen in the two groups. 
Mild and transient clinical side-effects were seen, such 
as vomiting in one child in each group and agitation in 
2 (6.6%) children of CH+M group. The adverse events 
were more frequent in CH+M group (p=0.04).
Discussion
Various drugs have been used for pediatric MRI sedation. 
The Results of this randomized clinical trial showed that 
combination of chloral hydrate at minimum dosage and 
hydroxyzine or midazolam were equally effective in 
children who underwent MRI.
In another Iranian study, adequate sedation and 
completion of CT scan examination were achieved in 
76.7% of children who aged 1-10 years and received 100 
mg/kg chloral hydrate orally (16).
In Mason et al.’s study, efficacy of oral chloral hydrate at 
a dosage of 50 mg/kg and oral pentobarbital were equal 
in MRI sedation of younger than 1-year-old infants; 
however, side-effects frequency was significantly lower 
in pentobarbital group (17).
However, Schulte-Uentrop and Goepfert concluded 
oxygen saturation of less than 90%, or a 25% or greater 
decrease in pre sedation mean arterial blood pressure 
were considered as serious side-effects.
Failure to achieve adequate sedation (patient’s 
wakening or movement, interfering with completion 
of MRI examination, inadequate sedation, and need 
for administration of other sedatives) and procedure 
abortion due to serious adverse events, were considered 
as failure of sedation regimen.
The developmental status of the patient was assessed by a 
pediatric neurologist based on Denver II Developmental 
screening test (15).
The strength of the MRI machine of our hospital was 1.5 
Tesla, and it had been manufactured by Siemens in 2010.
Non-contrast brain MRI of these children was interpreted 
by a pediatric neurologist and a radiologist using a three-
point scale: 1- good quality and no motion, 2= reportable 
and minor movement, and 3= non reportable and major 
movement. 
The data were analyzed using SPSS statistical software 
(version 17). Chi-square and Fisher’s exact tests were 
used for data analysis of qualitative variables, and mean 
values were compared by independent t-test.
Kaplan–Meier survival analysis was used to calculate 
probability of adequate sedation during the observation 
period. The differences were considered significant at 
p<0.05.
This study was registered in Iranian clinical trials with 
registration number IRCT201302092639N10.
Results
The design and conduct of this trial was straightforward, 
and we did not have any losses to follow-up or exclusions.
Twenty-eight girls (46.7%) and 32 boys (53.3%) with 
the mean age of 2.72±1.58 years were evaluated.
No statistically significant differences were observed 
between the two groups in terms of mean of age, mean 
of weight, sex distribution, developmental status, and 
age group of children in two groups (Table 1).
Adequate deep sedation (Ramsay sedation score of 
five) and completion of MRI examination was achieved 
in 23 (76.7%) children in chloral hydrate-hydroxyzine 
group [95% confidence interval (CI): 0.61-0.92] and 
in 22 (73.7%) children in chloral hydrate-midazolam 
group (95% CI: 0.58-0.89), and the statistical analysis 
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that in sedation induction for MRI, chloral hydrate, 
pentobarbital, and midazolam are not proper and 
dexmedetomidine may be a more effective drug in 
sedation induction in children without cardiac risk, and 
if anesthesiologists or pediatric intensivists are present, 
propofol can be used and general anesthesia is a preferred 
technique in preterm or small children (4).
In a study in Iowa, USA, a combination of 25 mg/kg 
chloral hydrate, 1 mg/kg hydroxyzine, and 1 mg/kg 
meperidine was more effective than 0.65 mg/kg of oral 
midazolam in sedation for dental procedures (18). 
In a study in Miami, USA, efficacy of chloral hydrate, 
combination of chloral hydrate and diphenhydramine, 
chloral hydrate-hydroxyzine hydrochloride combination 
and midazolam alone were compared in case of sedation 
induction for echocardiography. In chloral hydrate group, 
children fell asleep the most quickly and chloral hydrate 
and diphenhydramine group had the most prolonged 
sedations (19).
In a study in Mexico City, combination of 70 mg/
kg chloral hydrate and 2 mg/kg hydroxyzine in 
comparison with 70 mg/kg chloral hydrate alone caused 
a significantly more decrease in crying and movement 
within 45-60 minutes after a rubber dam insertion. But, 
in both groups, overall behavior was not different during 
the dental procedures (20).
In a study in Mexico, a combination of 0.50 mg/kg 
midazolam and 1.5 mg/kg hydroxyzine or 50 mg/kg 
chloral hydrate and 1.5 mg/kg hydroxyzine were more 
effective than 2 mg/kg hydroxyzine alone in sedation 
induction for dental procedures (21).
In the present study, the efficacy of both combination 
of the drugs in sedation induction were not statistically 
different in infants (less than two years old) and also 
in children. But, in a Korean study, chloral hydrate 
was more effective in MRI sedation of younger than 
18-month-old children (22).
In our study, the efficacy of both combinations of the 
drugs in sedation induction for MRI was not statistically 
different in children with and without developmental 
delay, which is in agreement with a study in the USA (23).
Possible explanations for these discrepancies include 
differences in age, drugs combination and dosage, race, 
sample size, type of procedure, etc.
In the present study, both sedation regimens were safe 
and no serious clinical adverse events were seen in the 
two groups. But, in Fávero et al.’s study, respiratory 
complications occurred in two of 41 children who 
received 50 mg/kg of chloral hydrate (24) and in Heistein 
et al.’s study in Texas, serious side-effects such as apnea 
occurred in 0.3%, airway obstruction in 1.4%, hypoxia 
in 5.9%, hypercapnia in 6.6%, and hypotension in 0.4% 
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Chloral hydrate
and midazolam p=value
Age in year (mean±SD) 2.93±1.56 2.51±1.59 0.3
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of children who were sedated with chloral hydrate for 
echocardiography (25).
In this research, achieving sleep in majority of children 
who were adequately sedated with the two sedation 
regimens appeared up to 40 minutes after administration 
of the drugs combination, therefore, administration of 
these sedative drugs in 40 minutes before the procedure 
could be more effective. 
In conclusion, results of the present study showed that 
a combination of chloral hydrate at minimum dosage 
and hydroxyzine or midazolam are equally effective in 
pediatric MRI sedation. But, a combination of chloral 
hydrate and hydroxyzine is safer.
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Table2. Comparison of Mean of Sedation Parameter Variables between the Two Groups
Group
Data 
Chloral hydrate and 
hydroxyzine 
Chloral hydrate and 
midazolam p-value
Acquired Ramsay sedation score 5.07± 1.23 4.71± 1.62 0.3
Time between drugs taking and reaching Ramsey 
score of five (in minute) 
18.91± 8.15 22.27± 9.22 0.2
Time after taking the drug to completing MRI 
examination (in minute)
33.95± 12.06 39.18± 11.21 0.1
Caregiver’s satisfaction scale 3.81±1.27 3.37± 1.41 0.2
Total stay time in radiology department (in minute) 69.1± 22.49 81.81± 23.24 0.03
Table 3. Comparison of Success in Completing MRI Examination in Both 
Groups Based On Developmental Status and Age Group
 Success in completing MRI



















* CH+H: Chloral hydrate and hydroxyzine 
** CH+M: Chloral hydrate and midazolam
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